In the ongoing fight against HIV, scientists have taken a new step toward long-term control of the virus. Researchers have ...

Innovative, nontoxic molecules developed by a research team at the Institut national de la recherche scientifique (INRS) ...

Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...

A cold sore might seem like a minor nuisance. But behind that tingling lip is one of the world’s most widespread and cunning viruses—herpes simplex virus type 1, or HSV-1. It infects billions of ...

In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a molecule within HIV itself can be manipulated and amplified to force the ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial progress. Many effective treatments are available for HIV, but these ...

The Peterson lab assessed the impact on ablating B cell follicles with CD20 CAR T cells in a non-human primate model of HIV persistence.

Viruses need host cells, and viral pathogens have many different ways to infect those hosts. Scientists have revealed a rapid movement made by a small molecule called a glycoprotein on the surface of ...

As the HIV virus glides up outside a human cell to dock and possibly inject its deadly cargo of genetic code, there’s a spectacularly brief moment in which a tiny piece of its surface snaps open to ...

HIV PROTEIN ‘MISREPRESENTED’ The prospective vaccine only contained an HIV protein, not the virus itself, a spokesperson for CSL told Reuters for a previous fact-check.

When the virus erodes the level of these protective T cells to a critically low point, a person becomes vulnerable to lethal infections — developing AIDS. Yet new research published today in the ...